{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:46:24Z","timestamp":1761597984410,"version":"3.41.2"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:00:00Z","timestamp":1536105600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"DOI":"10.3389\/fpubh.2018.00245","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T04:20:58Z","timestamp":1536121258000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Inflammatory Markers in Patients Using Domiciliary Non-invasive Mechanical Ventilation: C Reactive Protein, Procalcitonin, Neutrophil Lymphocyte Ratio"],"prefix":"10.3389","volume":"6","author":[{"given":"Birsen","family":"Ocakli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eylem","family":"Tuncay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinem","family":"Gungor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meltem","family":"Sertbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nalan","family":"Adiguzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilim","family":"Irmak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nezihe","family":"Ciftaslan Goksenoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emine","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huriye","family":"Berk Takir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem","family":"Yazicioglu Mocin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuhal","family":"Karakurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,5]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1378\/chest.116.2.521","article-title":"Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation \u2013 a consensus conference report","volume":"116","author":"Consensus","year":"1999","journal-title":"Chest"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0158843","DOI":"10.1371\/journal.pone.0158843","article-title":"A systematic review of diagnostic biomarkers of COPD exacerbation","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS ONE"},{"key":"B3","doi-asserted-by":"publisher","first-page":"112A","DOI":"10.1378\/chest.2281727","article-title":"Antimicrobial de-escalation based on filmarray respiratory panel and serum procalcitonin testing","volume":"148","author":"Sakata","year":"2015","journal-title":"Chest"},{"key":"B4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0140-6736(93)90277-N","article-title":"High serum procalcitonin concentrations in patients with sepsis and infection","volume":"341","author":"Assicot","year":"1993","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1378\/chest.11-0495","article-title":"Systemic biomarkers in exacerbations of COPD: the evolving clinical challenge","volume":"141","author":"Koutsokera","year":"2012","journal-title":"Chest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s10753-013-9749-1","article-title":"Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study","volume":"37","author":"G\u00fcnay","year":"2014","journal-title":"Inflammation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3904\/kjim.2015.084","article-title":"Usefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational study","volume":"31","author":"Lee","year":"2016","journal-title":"Korean J Intern Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2169\/internalmedicine.55.5772","article-title":"The neutrophil to lymphocyte ratio is related to disease severity and exacerbation in patients with chronic obstructive pulmonary disease","volume":"55","author":"Furutate","year":"2016","journal-title":"Intern Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.2147\/COPD.S88058","article-title":"Does eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit?","volume":"10","author":"Salt\u00fcrk","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1378\/chest.06-2336","article-title":"Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD","volume":"131","author":"Stolz","year":"2007","journal-title":"Chest"},{"key":"B11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/COPD.S16070","article-title":"Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease","volume":"6","author":"Lacoma","year":"2011","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.2147\/COPD.S132132","article-title":"Serum inflammatory biomarkers and clinical outcomes of COPD exacerbation caused by different pathogens","volume":"12","author":"Kawamatawong","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.15197\/ejgm.1554","article-title":"The predictive role of neutrophil to lymphocyte ratio in chronic obstructive pulmonary disease","volume":"13","author":"Bilir","year":"2016","journal-title":"Eur J Gen Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1378\/chest.06-2643","article-title":"Noninvasive ventilation for critical care","volume":"132","author":"Garpesta","year":"2007","journal-title":"Chest"},{"volume-title":"Global Strategy for the Diagnosis, Management and Prevention of COPD","year":"2014","author":"Global","key":"B15"},{"key":"B16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbations of chronic obstructive pulmonary","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Ann Intern Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.2147\/COPD.S147261","article-title":"Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker","volume":"12","author":"Tuncay","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"ATS\/ERS task force","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"B19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF01740811","article-title":"Procalcitonin\u2014a new indicator of the systemic response to severe infections","volume":"25","author":"Karzai","year":"1997","journal-title":"Infection"},{"key":"B20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/resp.12704","article-title":"Prognostic value of procalcitonin in pneumonia: a systematic review and meta-analysis","volume":"21","author":"Liu","year":"2016","journal-title":"Respirology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1741-7015-9-107","article-title":"Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future","volume":"9","author":"Schuetz","year":"2011","journal-title":"BMC Med."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/1479972318769762","article-title":"Comparison of procalcitonin, C-reactive protein, white blood cell count and clinical status in diagnosing pneumonia in patients hospitalized with acute exacerbations of COPD: a prospective observational study","author":"Titova","year":"2018","journal-title":"Chron Respir Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3892\/etm.2017.4496","article-title":"The levels of serum procalcitonin and high-sensitivity C-reactive protein in the early diagnosis of chronic obstructive pulmonary disease during acute exacerbation","volume":"14","author":"Gao","year":"2017","journal-title":"Exp Ther Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1515\/jomb-2017-0011","article-title":"Procalcitonin and CRP as biomarkers in discrimination of community-acquired pneumonia and exacerbation of COPD","volume":"36","author":"\u00c7olak","year":"2017","journal-title":"J Med Biochem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s00508-014-0690-6","article-title":"Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil\/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD","volume":"127","author":"Tanriverdi","year":"2015","journal-title":"Wien Klin Wochenschr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"R192","DOI":"10.1186\/cc9309","article-title":"Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit","volume":"14","author":"Jager","year":"2010","journal-title":"Crit Care"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e46561","DOI":"10.1371\/journal.pone.0046561","article-title":"The neutrophil-lymphocyte count ratio in patients with communityacquired pneumonia","volume":"7","author":"Jager","year":"2012","journal-title":"PLoS ONE"},{"key":"B28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13104-016-2335-5","article-title":"What is the normal value of the neutrophil-to-lymphocyte ratio?","volume":"10","author":"Forget","year":"2017","journal-title":"BMC Res Notes"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpubh.2018.00245\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T04:21:00Z","timestamp":1536121260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpubh.2018.00245\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,5]]},"references-count":28,"alternative-id":["10.3389\/fpubh.2018.00245"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2018.00245","relation":{},"ISSN":["2296-2565"],"issn-type":[{"type":"electronic","value":"2296-2565"}],"subject":[],"published":{"date-parts":[[2018,9,5]]},"article-number":"245"}}